Serum C terminal telopeptide maintains its correlation with bone disease in patients with myeloma even under treatment with bisphosphonates

被引：1
作者：
Pochintesta, Lara [1 ]
Mangiacavalli, Silvia [1 ]
Cocito, Federica [1 ]
Pompa, Alessandra [1 ]
Albertini, Riccardo [2 ]
Pascutto, Cristiana [1 ]
Ferretti, Virginia Valeria [1 ]
Cazzola, Mario [1 ]
Corso, Alessandro [1 ]
机构：
[1] Univ Pavia, Div Hematol, Dept Oncohematol, I-27100 Pavia, Italy
[2] Univ Pavia, Clin Chem Lab, Fdn IRCCS Policlin San Matteo, I-27100 Pavia, Italy
来源：
LEUKEMIA & LYMPHOMA | 2014年 / 55卷 / 06期
关键词：
MULTIPLE-MYELOMA; ZOLEDRONIC ACID; PAMIDRONATE; CANCER;
D O I：
10.3109/10428194.2013.830305
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1397 / 1398
页数：2
相关论文
共 8 条
  • [1] Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma
    Berenson, JR
    Lichtenstein, A
    Porter, L
    Dimopoulos, MA
    Bordoni, R
    George, S
    Lipton, A
    Keller, A
    Ballester, O
    Kovacs, MJ
    Blacklock, HA
    Bell, R
    Simeone, J
    Reitsma, DJ
    Heffernan, M
    Seaman, J
    Knight, RD
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (08) : 488 - 493
  • [2] Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis
    Black, Dennis M.
    Delmas, Pierre D.
    Eastell, Richard
    Reid, Ian R.
    Boonen, Steven
    Cauley, Jane A.
    Cosman, Felicia
    Lakatos, Peter
    Leung, Ping Chung
    Man, Zulema
    Mautalen, Carlos
    Mesenbrink, Peter
    Hu, Huilin
    Caminis, John
    Tong, Karen
    Rosario-Jansen, Theresa
    Krasnow, Joel
    Hue, Trisha F.
    Sellmeyer, Deborah
    Eriksen, Erik Fink
    Cummings, Steven R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (18) : 1809 - 1822
  • [3] Bisphosphonates: Clinical experience
    Coleman, RE
    [J]. ONCOLOGIST, 2004, 9 : 14 - 27
  • [4] The use of bisphosphonates in cancer treatment
    Coleman, Robert
    [J]. BISPHOSPHONATES AND OSTEONECROSIS OF THE JAW, 2011, 1218 : 3 - 14
  • [5] Review of 1027 patients with newly diagnosed multiple myeloma
    Kyle, RA
    Gertz, MA
    Witzig, TE
    Lust, JA
    Lacy, MQ
    Dispenzieri, A
    Fonseca, R
    Rajkumar, SV
    Offord, JR
    Larson, DR
    Plevak, ME
    Therneau, TM
    Greipp, PR
    [J]. MAYO CLINIC PROCEEDINGS, 2003, 78 (01) : 21 - 33
  • [6] Effect of withdrawal of zoledronic acid treatment on bone remodelling markers in multiple myeloma
    Lund, Thomas
    Abildgaard, Niels
    Delaisse, Jean-Marie
    Plesner, Torben
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2010, 151 (01) : 92 - 94
  • [7] Rosen LS, 2001, CANCER J, V7, P377
  • [8] The use of biochemical markers of bone remodeling in multiple myeloma: a report of the International Myeloma Working Group
    Terpos, E.
    Dimopoulos, M. A.
    Sezer, O.
    Roodman, D.
    Abildgaard, N.
    Vescio, R.
    Tosi, P.
    Garcia-Sanz, R.
    Davies, F.
    Chanan-Khan, A.
    Palumbo, A.
    Sonneveld, P.
    Drake, M. T.
    Harousseau, J-L
    Anderson, K. C.
    Durie, B. G. M.
    [J]. LEUKEMIA, 2010, 24 (10) : 1700 - 1712
1